InvestorsHub Logo
Followers 241
Posts 12376
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Friday, 05/01/2020 2:07:34 PM

Friday, May 01, 2020 2:07:34 PM

Post# of 44784
No company wants to use nearly all the share authorized before asking for growth from the shareholders. Frankly the company did the responsible thing on doing the R/S by reducing the authorized shares, I've seen many R/S's where that wasn't done, and in no time the O/S ballooned to nearly what it was prior to the R/S.

If we make the assumption that the company over the next couple years dilutes to 50 million shares outstanding, that's saying a billion dollar market cap would be a $20 share price. Does anyone here not believe that with success in CLI we won't be worth at least a few billion. Even without coronavirus that shouldn't be that long. Of course coronavirus is the joker, though I really should say pneumonia. If we gain approval, it will be tried for all forms of pneumonia, off label, but should become the SOC as in the majority of cases it will prevent the need for hospitalization. It may be expensive, but not nearly as expensive as time in the hospital, and it will eliminate many deaths that are pneumonia related. How many billion do people believe a pneumonia drug will bring in, can you see a double, or even triple digit billion market cap for PSTI with it. If we looked at a $10 billion market cap with 50 million shares outstanding, that's $200 a share. Any complaints.

Gary